Financhill
Buy
60

PTGX Quote, Financials, Valuation and Earnings

Last price:
$93.51
Seasonality move :
37.92%
Day range:
$91.07 - $93.07
52-week range:
$33.70 - $93.25
Dividend yield:
0%
P/E ratio:
145.67x
P/S ratio:
28.29x
P/B ratio:
8.94x
Volume:
800.8K
Avg. volume:
957.7K
1-year change:
125%
Market cap:
$5.8B
Revenue:
$434.4M
EPS (TTM):
$0.63

Protagonist Therapeutics, Inc. SEC Filings

Company Filed Form Type Description
PTGX
Protagonist Therapeutics, Inc.
11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
PTGX
Protagonist Therapeutics, Inc.
08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
PTGX
Protagonist Therapeutics, Inc.
05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
PTGX
Protagonist Therapeutics, Inc.
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
PTGX
Protagonist Therapeutics, Inc.
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
PTGX
Protagonist Therapeutics, Inc.
05/05/2022 10-Q 10-Q filing on 05/05/2022 View Form
PTGX
Protagonist Therapeutics, Inc.
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
PTGX
Protagonist Therapeutics, Inc.
08/04/2021 10-Q 10-Q filing on 08/04/2021 View Form
PTGX
Protagonist Therapeutics, Inc.
05/04/2021 10-Q 10-Q filing on 05/04/2021 View Form
PTGX
Protagonist Therapeutics, Inc.
11/04/2020 10-Q 10-Q filing on 11/04/2020 View Form
PTGX
Protagonist Therapeutics, Inc.
08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
PTGX
Protagonist Therapeutics, Inc.
05/07/2020 10-Q 10-Q filing on 05/07/2020 View Form
PTGX
Protagonist Therapeutics, Inc.
03/10/2020 10-K 10-K filing on 03/10/2020 View Form
PTGX
Protagonist Therapeutics, Inc.
11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
PTGX
Protagonist Therapeutics, Inc.
08/07/2019 10-Q 10-Q filing on 08/07/2019 View Form
PTGX
Protagonist Therapeutics, Inc.
05/08/2019 10-Q 10-Q filing on 05/08/2019 View Form
PTGX
Protagonist Therapeutics, Inc.
03/12/2019 10-K 10-K filing on 03/12/2019 View Form
PTGX
Protagonist Therapeutics, Inc.
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
PTGX
Protagonist Therapeutics, Inc.
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
PTGX
Protagonist Therapeutics, Inc.
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
PTGX
Protagonist Therapeutics, Inc.
03/07/2018 10-K 10-K filing on 03/07/2018 View Form
PTGX
Protagonist Therapeutics, Inc.
11/07/2017 10-Q 10-Q filing on 11/07/2017 View Form
PTGX
Protagonist Therapeutics, Inc.
08/08/2017 10-Q 10-Q filing on 08/08/2017 View Form
PTGX
Protagonist Therapeutics, Inc.
05/10/2017 10-Q 10-Q filing on 05/10/2017 View Form
PTGX
Protagonist Therapeutics, Inc.
03/07/2017 10-K 10-K filing on 03/07/2017 View Form
PTGX
Protagonist Therapeutics, Inc.
11/14/2016 10-Q 10-Q filing on 11/14/2016 View Form
PTGX
Protagonist Therapeutics, Inc.
09/15/2016 10-Q 10-Q filing on 09/15/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
54
SMX alert for Dec 12

SMX (Security Matters) Plc [SMX] is down 8.24% over the past day.

Buy
77
DHIL alert for Dec 12

Diamond Hill Investment Group, Inc. [DHIL] is up 0.04% over the past day.

Sell
28
OXM alert for Dec 12

Oxford Industries, Inc. [OXM] is up 10.45% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock